Products

Vivio® LVEDP System
Ventric Health
Cardiology AI
Vivio® is the first and only medical device to enable non-invasive diagnosis of heart failure within clinical or home health care environments, leveraging advanced algorithms to detect elevated left ventricular end-diastolic pressure (LVEDP).

See all 1 product →

About Ventric Health

Ventric Health is a Pasadena-based medical technology company focused on developing non-invasive solutions to assess cardiovascular health, particularly for the early detection of heart failure.

For physicians, the Vivio System offers a rapid, non-invasive method to diagnose heart failure in various settings, including primary care clinics and home healthcare environments. This allows for earlier identification of at-risk patients, potentially before structural damage and overt symptoms manifest, which is crucial given that heart failure symptoms often develop slowly and can be difficult to diagnose early. By providing objective, scientifically grounded cardiovascular data at the point of care, Vivio aims to empower clinicians to make more confident diagnoses, facilitate earlier treatment, and improve patient outcomes. The system’s ease of use and real-time results can also help overcome barriers to diagnosis, such as transportation limitations, and support value-based care goals by reducing healthcare costs and enabling proactive management of heart failure.

Focus Areas

cardiovascular health heart failure detection non-invasive diagnostics AI in healthcare value-based care

Business Intelligence

TechnologyThe Vivio System uses patented advanced hemodynamic algorithms and data measurements, combined with a physics-based analytical model of the cardiovascular system, to non-invasively indicate elevated LVEDP. It measures relationships between pressure waves from a pneumatic cuff and electrical signals from a single-lead ECG.

What Physicians Need to Know

Cardiovascular Health & Heart Failure Detection
Ventric Health specializes in the early and non-invasive detection of heart failure, particularly in primary care settings. Their core technology, the Vivio® System, is the first and only FDA-cleared non-invasive solution for definitively measuring Left Ventricular End Diastolic Pressure (LVEDP), a key indicator of heart failure. This allows for earlier diagnosis and intervention, potentially improving patient outcomes and reducing hospitalizations.
Non-Invasive Diagnostics
The Vivio® System provides a non-invasive, 3-minute test that can be performed in an exam room, eliminating the need for specialist referrals, costly procedures, or invasive catheterization. It uses a pneumatic cuff and a single-lead ECG to collect data, employing a physics-based analytical model to assess cardiac health.
AI in Healthcare (Physics-based approach)
While Ventric Health operates in the broader AI in healthcare space, their Vivio® System specifically utilizes advanced algorithms and a physics-based analytical model of the cardiovascular system, rather than AI or machine learning, to compute elevated LVEDP. This approach allows for accurate and rapid diagnosis.
Value-Based Care
Ventric Health's solutions are designed to support value-based care models by enabling earlier detection and treatment of heart failure, which can lead to reduced avoidable hospitalizations, emergency department visits, and overall healthcare costs. Their system helps primary care teams identify at-risk populations sooner, improving performance under various CMS programs.
Physician Tip

The Vivio® System offers a rapid (3-minute), non-invasive, and accurate method for detecting elevated LVEDP directly in your exam room, providing hospital-grade diagnostic clarity in a primary care setting. This can significantly aid in the early diagnosis of heart failure, allowing for timely initiation of guideline-directed medical therapy and potentially preventing disease progression and costly hospitalizations. The system is designed for straightforward implementation into clinical workflows and includes training for clinicians and staff. It can empower primary care physicians to confidently identify and triage patients with early-stage heart failure, even before overt symptoms manifest.

The Vivio platform is built to meet modern healthcare security and privacy expectations, supporting secure handling of protected health information and integrating safely with EHR systems. This allows for seamless incorporation of diagnostic data into existing patient records and workflows.

Products by Ventric Health

1 product in the directory

Vivio® LVEDP System
Ventric Health
Cardiology AI
Vivio® is the first and only medical device to enable non-invasive diagnosis of heart failure within clinical or home health care environments, leveraging advanced algorithms to detect elevated left ventricular end-diastolic pressure (LVEDP).

Videos

News, demos, and interviews about Ventric Health.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ventric Health →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Ventric Health is a medical technology company primarily focused on the earlier detection of heart failure. Their core product, the Vivio System, non-invasively measures Left Ventricular End-Diastolic Pressure (LVEDP), which is a definitive indicator of heart failure, aiming to identify the condition before symptoms significantly worsen.
The Vivio System is the first and only FDA-cleared medical device that non-invasively measures LVEDP, the hallmark of heart failure, in a quick, five-minute test. It utilizes a modified blood pressure cuff, a Bluetooth-enabled ECG, and advanced algorithms to provide real-time results, offering a non-invasive alternative to traditional, often invasive, diagnostic methods like cardiac catheterization.
Yes, the Vivio System is designed for use in both primary care offices and home health care environments. Its portability and ease of use allow clinicians to perform the five-minute test in various settings, expanding access to early heart failure diagnosis and helping overcome barriers to care for at-risk populations.
Ventric Health's Vivio System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance enables clinicians to non-invasively diagnose heart failure within both clinical and home health care settings, ensuring the device meets established regulatory standards for safety and effectiveness.
While specific details on comprehensive support programs are not explicitly outlined, Ventric Health's mission to enable widespread adoption implies a commitment to supporting clinicians. They provide resources including clinical studies and white papers, and aim to ensure their solutions are aligned with real-world care pathways for successful integration and optimal use.
Ventric Health actively seeks to foster partnerships with healthcare providers, academic institutions, and industry leaders to drive innovation and improve patient outcomes. They collaborate with value-based care organizations and payers to expand their heart failure management model and make advanced, non-invasive testing more accessible.
Founded in 2014, Ventric Health has secured significant funding, including $13.1 million, demonstrating investor confidence. Their Vivio System is already in use across the country, with nearly 30,000 tests performed, indicating growing market adoption and a stable operational presence.

Related Companies

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

MediSync AI is a healthcare AI company focused on transforming patient care and boosting revenue through AI-driven solutions, particularly in Remote Patient Monitoring (RPM). Their platform extends healthcare beyond traditional boundaries, offering continuous care to patients wherever they are. They aim to enhance patient experience and outcomes while providing tools for clinicians and revenue optimization […]

Snore Screen offers an AI-powered craniofacial screening tool designed to identify the risk of obstructive sleep apnea (OSA) in under 60 seconds using a single facial scan. This non-invasive optical phenotyping technology helps physicians prioritize clinical referrals, reduce sleep lab backlogs, and streamline patient triage. The platform analyzes craniofacial markers, such as mandibular structure, neck […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.